Introduction
Calcium is one of the most important electrolytes that is necessary for different physiological processes. Hypercalcemia is a disorder associated with many clinical manifestations varying from asymptomatic to lifethreatening clinical situations while these manifestations are regardless of the background etiology (1) . It should also be noted that symptoms of neurological dysfunction are often predominant in hypercalcemia. Etiologies of hypercalcemia are very different but primary hyperparathyroidism and malignancies are the most common etiologies. Pseudohypercalcemia is defined as elevated calcium concentration along with normal ionized calcium which might be due to binding of calcium to elevated serum proteins (2) . Multiple myeloma is a plasma cell neoplasm and clinically significant hypercalcemia is reported in 1 of 3 multiple myeloma patients (3). The etiology of true hypercalcemia in multiple myeloma patients is due to diffuse bone break down and release of calcium but pseudohypercalcemia is very rare. Here we describe a 60-year-old man admitted and diagnosed with multiple myeloma which had asymptomatic elevated calcium concentration and was finally diagnosed with pseudohypercalcemia.
Case Presentation
A 60-year-old man was admitted to Al-Zahra hospital, Isfahan due to generalized pain in his limbs (mostly aggregated at nights), anorexia and weight loss (approximately 20 kg within the last three months). His limb pain lasted almost 3 hours at nights and did not respond to common analgesics such as nonsteroidal antiinflammatory drugs. The patient had a history of controlled diabetes mellitus from one year ago. Four months prior Here in this paper, we present a 60-year-old man admitted for generalized pain in his limbs and was finally diagnosed with multiple myeloma. He also underwent evaluation and treatments for his hypercalcemia (15 mg/dL). His calcium concentration did not respond well to different modalities and was along with a low parathyroid hormone (PTH) and elevated creatinine concentration (12 mg/dL). Further evaluations revealed normal ionized calcium which confirmed the diagnosis of pseudohypercalcemia. Multiple myeloma is a plasma cell neoplasm in which 10% of the patients suffer from true-hypercalcemia at the time of diagnosis. Pseudohypercalcemia is described as an elevated serum calcium concentration along with normal ionized calcium concentration and the absence of clinical symptoms of hypercalcemia. The cause of pseudohypercalcemia in multiple myeloma is due to the binding of calcium to increased abnormal immunoglobulins. The importance of this issue lies in the low PTH levels along with hypercalcemia and azotemia which is suggestive of pseudohypercalcemia.
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to his admission, he experienced multiple lumbar spinal compression fractures. He had no family history of hypercalcemia or any other endocrine or hematologic diseases. His drug history contained metformin 500 mg twice daily. In his primary physical examinations, the patient had a body temperature of 37°C with a heart rate of 88 beats/min and blood pressure of 130/85 mm Hg. He had generalized bone pain however no tenderness was observed. He could not walk properly due to his former spinal fracture. All other physical examinations were normal. His initial laboratory data indicated serum calcium of 15 mg/dL with a normal albumin concentration (4.6 g/dL) and anemia with a hemoglobin of 6.2 g/dL.
He also had elevated serum creatinine 12 mg/dL which was suggestive of acute renal failure. Our patient had a low PTH concentration (10.1 pg/mL) and his urinary analysis indicated proteinuria (3+) and glycosuria (1+). All his initial laboratory data are summarized in Tables 1,  2 and 3 . The clinical and laboratory data made our patient suspicion to multiple myeloma. His calcium concentration did not respond well to calcitonin. The patient scheduled for hemodialysis for his elevated calcium and creatinine. Serum calcium and creatinine decreased to 13 mg/dL and 4.3 mg/dL respectively then we became suspicious to pseudohypercalcemia according to no dramatic changes in serum calcium.
As the next step, serum and urinary protein electrophoresis and immunofixation were conducted for the diagnosis of multiple myeloma. Bence Jones protein was positive. Monoclonal gammopathy (IgA lambda) in serum (Figures 1 and 2 ) was detected. Bone marrow aspiration and biopsy showed diffuse plasma cell dyscrasia with diffuse infiltration of myeloma cells occupied more than 75% of marrow parenchyma (Figure 3) . Therefore, the diagnosis of multiple myeloma was confirmed. Ionized calcium concentration was 1.31 mmol/L (normal range; 1.12 to 1.32 mmol/L). Accordingly we diagnosed pseudohypercalcemia by a normal ionized calcium concentration along with elevated total calcium in the serum. Afterwards, the patient underwent anti-myeloma treatments (bortezomib, thalidomide, and dexamethasone) and no further treatments were performed for his calcium concentration. The patient was then discharged within 12 days after anti-myeloma treatments with the total calcium concentration of 9.8 mg/dL. Laboratory data at the time of discharge are summarized in Table 4 . Follow up serum calcium after 4 weeks was also 9 mg/dL. hypergammaglobulinemia, dehydration and excessive serum albumin (4) . In this state, calcium binds to proteins in serum but ionized calcium concentration remains normal without no signs and symptoms of hypercalcemia (2) . As Shane and colleagues reported (1), true hypercalcemia is a condition in which serum calcium concentration and ionized calcium are elevated while symptoms of hypercalcemia are present. Symptoms of hypercalcemia including, gastrointestinal symptoms, loss of consciousness, polydipsia, polyuria and dehydration. True hypercalcemia can be caused by many reasons but is a common complication of multiple myeloma(3). As we described earlier, our patient had none of such symptoms however, he had an elevated calcium concentration. There had been similar cases with pseudohypercalcemia in patients with multiple myeloma (5-7). As Cicci et al described (8) , hypercalcemia can complicate the management of myeloma by precipitating dehydration and prerenal azotemia as our patient had azotemia. It has been also reported that a standard approach to hypercalcemia following a malignancy is fluid resuscitation (9). However as we described, administration of intravenous fluid therapy was contraindicated due to decreased glomerular filtration rate.
Conclusion
Taken together, physicians must be careful and aware of pseudohypercalcemia in patients with multiple myeloma who have low PTH level despite renal failure. In such situations, ionized calcium concentration is suggested to be measured at the first step to prevent unnecessary treatments.
